Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ · Manufacturing · Pharmaceutical preparations
$6.25−$0.1279 (−2.00%) on the dayAs of the close; data may be delayed.
QNRX price, last 12 months
Key stats
- Previous close
- $6.38
- Open
- $6.40
- Day range
- $6.25 – $6.69
- 52-week range
- $3.25 – $41.80
- Volume
- 8.4K
- Avg volume (20 days)
- 1.7M
- Market cap
- $12.9M
Performance
1W−11.4%
1M+20.7%
3M+40.5%
6M−17.4%
YTD−56.7%
1Y−10.9%
vs S&P 500, 1Y−27.7 pts
Technicals and fundamentals
About Quoin Pharmaceuticals, Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $12.9M